Reduced level of plasma antioxidant uric acid in schizophrenia

Psychiatry Research

Volumn 80, Issue 1, 1998, Pages 29-39

  Yao, Jeffrey K ^a,b   Reddy, Ravinder ^b   Van Kammen, Daniel P ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antioxidant defense system; Haloperidol; Plasma uric acid; Psychosis

Indexed keywords

ANTIOXIDANT; COTININE; HALOPERIDOL; NEUROLEPTIC AGENT; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; URIC ACID BLOOD LEVEL;

ADULT; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; COTININE; HALOPERIDOL; HUMANS; MALE; SCHIZOPHRENIA; SMOKING; URIC ACID;

EID: 0032572555     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00051-1     Document Type: Article

References (42)

1. Abdalla, D.S.P., Manteiro, H.P., Olivera, J.A.C., Bechara, C.H., 1986. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic depressive patients. Clinical Chemistry 32, 805-807.
2. Andreasen, N.C., 1982. Negative symptoms in schizophrenia: definition and reliability. Archives of General Psychiatry 39, 784-794.
3. Becker, B.F., 1993. Towards the physiological function of uric acid. Free Radical Biology and Medicine 14, 615-631.
4. Bunney, W.E., Hamburg, D.A., 1963. Methods for reliable longitudinal observation of behavior. Archives of General Psychiatry 19, 280-294.
5. Cadet, J.L., Lohr, J.B., 1987. Free radicals and the developmental pathology of schizophrenic burnout. Integrative Psychiatry 5, 40-48.
6. Chow, K.C., 1992. Vitamin E and cigarette smoking-induced oxidative damage. In: Packer, L., Fuchs, J. (Eds.), Vitamin E in Health and Disease. Marcel Decker, New York, pp. 683-697.
7. Davies, K.J.A., Sevanian, A., Muakkassah-Kelly, S.F., Hochstein, P., 1986. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochemistry Journal 235, 747-754.
8. Hall, S.M., Herning, R.I., Jones, R.T., Benowitz, N.L., Jacob, P. III, 1984. Blood cotinine levels as indicators of smoking treatment outcome. Clinical Pharmacology and Therapeutics 35, 810-814.
9. Horrobin, D.F., Manku, M.S., Hillman, H., Iain, A., Glen, M., 1991. Fatty acid levels in the brains of schizophrenics and normal controls. Biological Psychiatry 30, 795-805.
10. Jarvis, M.J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., Saloojee, Y., 1987. Comparison of tests used to distinguish smokers from nonsmokers. American Journal of Public Health 77, 1435-1438.
11. Kovaleva, E.S., Orlov, O.N., Tsutsul'kovskia, M.I.A., Vladimirova, T.V., Beliaev, T.S., 1989. Lipid peroxidation processes in patients with schizophrenia. Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova 89, 108-110.
12. Lam, K.W., Fong, D., Lee, A., Liu, K.M.D., 1984. Inhibition of ascorbate oxidation by urate. Journal of Inorganic Biochemistry 22, 241-248.
13. Langone, J.J., Gjika, H.B., van Vunakis, H., 1973. Nicotine and its metabolites. Radioimmunoassay for nicotine and cotinine. Biochemistry 12, 5025-5030.
14. Langone, J.J., van Vunakis, H., Hill, P., 1975. Quantitation of cotinine in sera of smokers. Research Communications in Chemical Pathology and Pharmacology 10, 21.
15. Lohr, J.B., Kuczenski, R., Bracha, H.S., Moir, M., Jeste, D.V., 1990. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biological Psychiatry 28, 535-539.
16. Mahadik, S.P., Mukherjee, S., Correnti, E.E., Sheffer, R., 1995. Elevated levels of lipid peroxidation products in plasma from drug-naïve patient at onset of psychosis. Schizophrenia Research 15, 66.
17. Miller, N.J., Rice-Evans, C., Davies, M.J., Gopinathan, V., Miller, A., 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical Science 84, 407-412.
18. Murthy, J.N., Laev, H., Karpiak, S., Mahadik, S., 1989. Enzymes of oxyradical metabolism after haloperidol treatment in rat. Social Neuroscience (Abstract) 15, 139.
19. Overall, J.E., Gorham, D.R., 1962. The Brief Psychiatric Rating Scale. Psychological Reports 10, 799-812.
20. Papas, A.M., 1996. Determinants of antioxidant status in humans. Lipids 31, S77-S82.
21. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophrenia Bulletin 19, 35-53.
22. Phillips, M., Sabas, M., Greenberg, J., 1993. Increased pentane and carbon disulfide in the breath of patients with schizophrenia. Journal of Clinical Pathology 46, 861-864.
23. Prilipko, L.L., 1992. The possible role of lipid peroxidation in the pathophysiology of mental disorders, In: Packer, L., Prilipko, L., Christen, Y. (Eds.), Free Radicals in the Brain. Spinger-Verlag, Berlin, pp. 146-152.
24. Pryor, W.A., Stone, K., 1992. Oxidants in cigarette smoke. Annals of the New York Academy of Sciences 686, 29.
25. Reddy, R., Mahadik, S.P., Mukherjee, M., Murthy, J.N., 1991. Enzymes of the antioxidant system in chronic schizophrenic patients. Biological Psychiatry 30, 409-412.
26. Reddy, R., Yao, J.K., 1996. Free radical pathology in schizophrenia: a review. Prostaglandins Leukotrienes and Essential Fatty Acids 55, 33-43.
27. Sevanian, A., Davies, K.J.A., Hochstein, P., 1991. Serum urate as an antioxidant for ascorbic acid. American Journal of Clinical Nutrition 54, 1129S-1134S.
28. Sirota, P., Melamed, Y., Dicker, D.R., Fisman, P., 1997. Superoxide anion production by neutrophils derived from peripheral blood of schizophrenic patients. Biological Psychiatry 41, 112S.
29. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1989. Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P). New York State Psychiatric Institute, New York.
30. Stegmayr, B., Johansson, I., Huhtasaari, F., Asplund, K., 1993. Use of smokeless tobacco and cigarettes - effects on plasma levels of antioxidant vitamins. International Vitamin Nutrition Research 63, 195-200.
31. Stocks, J., Gutteridge, J.M., Sharp, R.J., Dormandy, T.L., 1974. The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol. Clinical Science and Molecular Medicine 47, 223-233.
32. Vaiva, G., Thomas, P., Leroux, J.M., Cottencin, O., Dutoit, D., Erb, F., Goudemand, M., 1994. Erythrocyte superoxide dismutase (eSOD) determination in positive moments of psychosis. Therapie 49, 343-348.
33. van Kammen, D.P., Peters, J., van Kammen, W.B., Nugent, A., Goetz, K.L., Yao, J., Linnoila, M., 1989. Elevated CSF NE and relapse in schizophrenia. Biological Psychiatry 26, 178-188.
34. Wang, H., 1992. An investigation on changes in blood CuZn-superoxide dismutase contents in type I, II schizophrenics. Chung Hua Shen Ching Ching Shen Ko Tsa Chih 25, 6-8.
35. Wayner, D.D.M., Burton, G.W., Ingold, K.U., Barclay, L.R.C., Locke, S.J., 1987. The relative contribution of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochimica et Biophysica Acta 924, 408-419.
36. Yao, J.K., van Kammen, D.P., 1994. Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity. Schizophrenia Research 11, 209-216.
37. Yao, J.K., Reddy, R.D., McElhinny, L.G., van Kammen, D.P., 1998. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophrenia Research (in press).
38. 3H]arachidonic acid into platelet phospholipids of patients with schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids 55, 21-26.
39. Yao, J.K., van Kammen, D.P., Gurklis, J., 1994a. Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures. Schizophrenia Research 13, 227-232.
40. Yao, J.K., van Kammen, D.P., Gurklis, J., 1996a. Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia. Psychiatry Research 60, 11-21.
41. Yao, J.K., van Kammen, D.P., Moss, H.B., Sokulski, D.E., 1996b. A decreased serotonergic responsivity in platelets of unmedicated patients with schizophrenia. Psychiatry Research 63, 123-132.
42. Yao, J.K., van Kammen, D.P., Welker, J.A., 1994b. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophrenia Research 13, 217-226.